REGISTERED
on 28 Nov 2023
Last Applicant/ Owned by
55 CAMBRIDGE PARKWAY, SUITE 800E
CAMBRIDGE
MA
02142
Serial Number
90010383 filed on 19th Jun 2020
Registration Number
7231137 registered on 28th Nov 2023
Correspondent Address
Christina M. Licursi
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
EMPRESS THERAPEUTICS
pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
Classification Information
Class [005]
Pharmaceutical Products
pharmaceutical preparations and therapeutic pharmaceuticals, both for the treatment of cancer, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders
First Use Date in General
13th Sep 2023
First Use Date in Commerce
13th Sep 2023
Mark Details
Serial Number
No 90010383
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 28th Nov 2023 | REGISTERED-PRINCIPAL REGISTER |
| 28th Nov 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 25th Oct 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 24th Oct 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 03rd Oct 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 03rd Oct 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 22nd Sep 2023 | TEAS STATEMENT OF USE RECEIVED |
| 22nd Sep 2023 | USE AMENDMENT FILED |
| 30th Mar 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 28th Mar 2023 | SOU TEAS EXTENSION RECEIVED |